메뉴 건너뛰기




Volumn , Issue , 2009, Pages 112-126

Inhibitors of angiogenesis based on thrombospondin-1

Author keywords

[No Author keywords available]

Indexed keywords


EID: 77951195026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/97816080500481090101112     Document Type: Chapter
Times cited : (3)

References (154)
  • 1
    • 20144379162 scopus 로고    scopus 로고
    • Endogenous inhibitors of angiogenesis
    • Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res 2005; 65(10): 3967-3979.
    • (2005) Cancer Res , vol.65 , Issue.10 , pp. 3967-3979
    • Nyberg, P.1    Xie, L.2    Kalluri, R.3
  • 2
    • 0037360164 scopus 로고    scopus 로고
    • Thrombospondins 1 and 2 function as inhibitors of angiogenesis
    • Armstrong LC, Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 2003; 22(1): 63-71.
    • (2003) Matrix Biol , vol.22 , Issue.1 , pp. 63-71
    • Armstrong, L.C.1    Bornstein, P.2
  • 3
    • 0035940429 scopus 로고    scopus 로고
    • Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
    • Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 2001; 98(22): 12485-12490.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , Issue.22 , pp. 12485-12490
    • Rodriguez-manzaneque, J.C.1    Lane, T.F.2    Ortega, M.A.3    Hynes, R.O.4    Lawler, J.5    Iruela-arispe, M.L.6
  • 4
    • 0037079243 scopus 로고    scopus 로고
    • Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice
    • Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Oliver G, Jackson DG, Detmar M. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 2002; 21(52): 7945-7956.
    • (2002) Oncogene , vol.21 , Issue.52 , pp. 7945-7956
    • Hawighorst, T.1    Oura, H.2    Streit, M.3    Janes, L.4    Nguyen, L.5    Brown, L.F.6    Oliver, G.7    Jackson, D.G.8    Detmar, M.9
  • 6
    • 0041785511 scopus 로고    scopus 로고
    • Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1
    • Volpert OV, Alani RM. Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. Cancer Cell 2003; 3(3): 199-200.
    • (2003) Cancer Cell , vol.3 , Issue.3 , pp. 199-200
    • Volpert, O.V.1    Alani, R.M.2
  • 7
    • 0032552020 scopus 로고    scopus 로고
    • p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma
    • Holmgren L, Jackson G, Arbiser J. p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma. Oncogene 1998; 17(7): 819-824.
    • (1998) Oncogene , vol.17 , Issue.7 , pp. 819-824
    • Holmgren, L.1    Jackson, G.2    Arbiser, J.3
  • 8
    • 0028609624 scopus 로고
    • Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
    • Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994; 54: 6504-6511.
    • (1994) Cancer Res , vol.54 , pp. 6504-6511
    • Weinstat-saslow, D.L.1    Zabrenetzky, V.S.2    VanHoutte, K.3    Frazier, W.A.4    Roberts, D.D.5    Steeg, P.S.6
  • 10
    • 0036168401 scopus 로고    scopus 로고
    • Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma
    • Kragh M, Quistorff B, Tenan M, Van Meir EG, Kristjansen PE. Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma. Cancer Res 2002; 62(4): 1191-1195.
    • (2002) Cancer Res , vol.62 , Issue.4 , pp. 1191-1195
    • Kragh, M.1    Quistorff, B.2    Tenan, M.3    Meir, E.G.V.4    Kristjansen, P.E.5
  • 11
    • 0032770860 scopus 로고    scopus 로고
    • Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
    • Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J, Detmar M. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 1999; 155(2): 441-452.
    • (1999) Am J Pathol , vol.155 , Issue.2 , pp. 441-452
    • Streit, M.1    Velasco, P.2    Brown, L.F.3    Skobe, M.4    Richard, L.5    Riccardi, L.6    Lawler, J.7    Detmar, M.8
  • 12
    • 0025147371 scopus 로고
    • A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
    • Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc.Natl.Acad.Sci.USA 1990; 87: 6624-6628.
    • (1990) Proc.Natl.Acad.Sci.USA , vol.87 , pp. 6624-6628
    • Good, D.J.1    Polverini, P.J.2    Rastinejad, F.3    Beau, M.M.L.4    Lemons, R.S.5    Frazier, W.A.6    Bouck, N.P.7
  • 13
    • 0025370524 scopus 로고
    • Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor
    • Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 1990; 111(2): 765-772.
    • (1990) J Cell Biol , vol.111 , Issue.2 , pp. 765-772
    • Taraboletti, G.1    Roberts, D.2    Liotta, L.A.3    Giavazzi, R.4
  • 15
    • 0028157338 scopus 로고
    • Matrix-bound thrombospondin promotes angiogenesis in vitro
    • Nicosia RF, Tuszynski GP. Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 1994; 124: 183-193.
    • (1994) J Cell Biol , vol.124 , pp. 183-193
    • Nicosia, R.F.1    Tuszynski, G.P.2
  • 16
    • 0027745333 scopus 로고
    • Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide
    • BenEzra D, Griffin BW, Maftzir G, Aharonov O. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophtalmol Vis Sci 1993; 34: 3601-3608.
    • (1993) Invest Ophtalmol Vis Sci , vol.34 , pp. 3601-3608
    • BenEzra, D.1    Griffin, B.W.2    Maftzir, G.3    Aharonov, O.4
  • 17
    • 0033813281 scopus 로고    scopus 로고
    • The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells
    • Taraboletti G, Morbidelli L, Donnini S, Parenti A, Granger HJ, Giavazzi R, Ziche M. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. Faseb J 2000; 14(12): 1674-1676.
    • (2000) Faseb J , vol.14 , Issue.12 , pp. 1674-1676
    • Taraboletti, G.1    Morbidelli, L.2    Donnini, S.3    Parenti, A.4    Granger, H.J.5    Giavazzi, R.6    Ziche, M.7
  • 18
    • 0034492232 scopus 로고    scopus 로고
    • Cell contactdependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1
    • Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD. Cell contactdependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 2000; 11(9): 2885-2900.
    • (2000) Mol Biol Cell , vol.11 , Issue.9 , pp. 2885-2900
    • Chandrasekaran, L.1    He, C.Z.2    Al-barazi, H.3    Krutzsch, H.C.4    Iruela-arispe, M.L.5    Roberts, D.D.6
  • 19
    • 1542313880 scopus 로고    scopus 로고
    • Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo
    • Calzada MJ, Zhou L, Sipes JM, Zhang J, Krutzsch HC, Iruela-Arispe ML, Annis DS, Mosher DF, Roberts DD. Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo. Circ Res 2004; 94(4): 462-470.
    • (2004) Circ Res , vol.94 , Issue.4 , pp. 462-470
    • Calzada, M.J.1    Zhou, L.2    Sipes, J.M.3    Zhang, J.4    Krutzsch, H.C.5    Iruela-arispe, M.L.6    Annis, D.S.7    Mosher, D.F.8    Roberts, D.D.9
  • 20
    • 0033613226 scopus 로고    scopus 로고
    • Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats
    • Iruela-Arispe ML, Lombardo M, Krutzsch HC, Lawler J, Roberts DD. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 1999; 100(13): 1423-1431.
    • (1999) Circulation , vol.100 , Issue.13 , pp. 1423-1431
    • Iruela-arispe, M.L.1    Lombardo, M.2    Krutzsch, H.C.3    Lawler, J.4    Roberts, D.D.5
  • 21
    • 0035280238 scopus 로고    scopus 로고
    • Integrin-associated protein (CD47) and its ligands
    • Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001; 11(3): 130-135.
    • (2001) Trends Cell Biol , vol.11 , Issue.3 , pp. 130-135
    • Brown, E.J.1    Frazier, W.A.2
  • 22
    • 14844359865 scopus 로고    scopus 로고
    • Functional regulation of T lymphocytes by modulatory extracellular matrix proteins
    • Kuznetsova SA, Roberts DD. Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int J Biochem Cell Biol 2004; 36(6): 1126-1134.
    • (2004) Int J Biochem Cell Biol , vol.36 , Issue.6 , pp. 1126-1134
    • Kuznetsova, S.A.1    Roberts, D.D.2
  • 24
    • 0034833822 scopus 로고    scopus 로고
    • CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
    • Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001; 108(6): 785-791.
    • (2001) J Clin Invest , vol.108 , Issue.6 , pp. 785-791
    • Febbraio, M.1    Hajjar, D.P.2    Silverstein, R.L.3
  • 25
    • 0026567377 scopus 로고
    • Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro
    • Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992; 148(1): 78-83.
    • (1992) J Immunol , vol.148 , Issue.1 , pp. 78-83
    • Swerlick, R.A.1    Lee, K.H.2    Wick, T.M.3    Lawley, T.J.4
  • 27
    • 0032570699 scopus 로고    scopus 로고
    • Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif
    • Crombie R, Silverstein R. Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. J Biol Chem 1998; 273(9): 4855-4863.
    • (1998) J Biol Chem , vol.273 , Issue.9 , pp. 4855-4863
    • Crombie, R.1    Silverstein, R.2
  • 28
    • 0031983724 scopus 로고    scopus 로고
    • Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva
    • Crombie R, Silverstein RL, MacLow C, Pearce SF, Nachman RL, Laurence J. Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 1998; 187(1): 25-35.
    • (1998) J Exp Med , vol.187 , Issue.1 , pp. 25-35
    • Crombie, R.1    Silverstein, R.L.2    MacLow, C.3    Pearce, S.F.4    Nachman, R.L.5    Laurence, J.6
  • 29
    • 3242772439 scopus 로고    scopus 로고
    • The thrombospondin type 1 repeat superfamily
    • Tucker RP. The thrombospondin type 1 repeat superfamily. Int J Biochem Cell Biol 2004; 36(6): 969-974.
    • (2004) Int J Biochem Cell Biol , vol.36 , Issue.6 , pp. 969-974
    • Tucker, R.P.1
  • 30
    • 26444476029 scopus 로고    scopus 로고
    • Identification of CD36 molecular features required for its in vitro angiostatic activity
    • Primo L, Ferrandi C, Roca C, Marchio S, di Blasio L, Alessio M, Bussolino F. Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 2005; 19(12): 1713-1715.
    • (2005) FASEB J , vol.19 , Issue.12 , pp. 1713-1715
    • Primo, L.1    Ferrandi, C.2    Roca, C.3    Marchio, S.4    di Blasio, L.5    Alessio, M.6    Bussolino, F.7
  • 31
    • 0342445431 scopus 로고    scopus 로고
    • Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
    • Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6(1): 41-48.
    • (2000) Nat Med , vol.6 , Issue.1 , pp. 41-48
    • Jimenez, B.1    Volpert, O.V.2    Crawford, S.E.3    Febbraio, M.4    Silverstein, R.L.5    Bouck, N.6
  • 32
    • 33748747969 scopus 로고    scopus 로고
    • CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1
    • Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006; 281(36): 26069-26080.
    • (2006) J Biol Chem , vol.281 , Issue.36 , pp. 26069-26080
    • Isenberg, J.S.1    Ridnour, L.A.2    Dimitry, J.3    Frazier, W.A.4    Wink, D.A.5    Roberts, D.D.6
  • 33
    • 0036104828 scopus 로고    scopus 로고
    • Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor
    • Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 2002; 8(4): 349-357.
    • (2002) Nat Med , vol.8 , Issue.4 , pp. 349-357
    • Volpert, O.V.1    Zaichuk, T.2    Zhou, W.3    Reiher, F.4    Ferguson, T.A.5    Stuart, P.M.6    Amin, M.7    Bouck, N.P.8
  • 34
    • 58649096802 scopus 로고    scopus 로고
    • Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1
    • Rege TA, Stewart J, Jr., Dranka B, Benveniste EN, Silverstein RL, Gladson CL. Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1. J Cell Physiol 2009; 218(1): 94-103.
    • (2009) J Cell Physiol , vol.218 , Issue.1 , pp. 94-103
    • Rege, T.A.1    Stewart Jr, J.2    Dranka, B.3    Benveniste, E.N.4    Silverstein, R.L.5    Gladson, C.L.6
  • 35
    • 0029862392 scopus 로고    scopus 로고
    • Thrombospondin modulates alpha v beta 3 function through integrin-associated protein
    • Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J Cell Biol 1996; 135(2): 533-544.
    • (1996) J Cell Biol , vol.135 , Issue.2 , pp. 533-544
    • Gao, A.G.1    Lindberg, F.P.2    Dimitry, J.M.3    Brown, E.J.4    Frazier, W.A.5
  • 36
  • 38
    • 0033230597 scopus 로고    scopus 로고
    • Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis
    • Kanda S, Shono T, Tomasini-Johansson B, Klint P, Saito Y. Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis. Exp Cell Res 1999; 252(2): 262-272.
    • (1999) Exp Cell Res , vol.252 , Issue.2 , pp. 262-272
    • Kanda, S.1    Shono, T.2    Tomasini-johansson, B.3    Klint, P.4    Saito, Y.5
  • 40
    • 38449103435 scopus 로고    scopus 로고
    • Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1
    • Nunes SS, Outeiro-Bernstein MA, Juliano L, Vardiero F, Nader HB, Woods A, Legrand C, Morandi V. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1. J Cell Physiol 2008; 214(3): 828-837.
    • (2008) J Cell Physiol , vol.214 , Issue.3 , pp. 828-837
    • Nunes, S.S.1    Outeiro-bernstein, M.A.2    Juliano, L.3    Vardiero, F.4    Nader, H.B.5    Woods, A.6    Legrand, C.7    Morandi, V.8
  • 41
    • 0042170209 scopus 로고    scopus 로고
    • Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration
    • Orr AW, Elzie CA, Kucik DF, Murphy-Ullrich JE. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 2003; 116(Pt 14): 2917-2927.
    • (2003) J Cell Sci , vol.116 , Issue.14 PT , pp. 2917-2927
    • Orr, A.W.1    Elzie, C.A.2    Kucik, D.F.3    Murphy-ullrich, J.E.4
  • 42
    • 0029007213 scopus 로고
    • Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1
    • Godyna S, Liau G, Popa I, Stefansson S, Argraves WS. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol 1995; 129(5): 1403-1410.
    • (1995) J Cell Biol , vol.129 , Issue.5 , pp. 1403-1410
    • Godyna, S.1    Liau, G.2    Popa, I.3    Stefansson, S.4    Argraves, W.S.5
  • 43
    • 39449127385 scopus 로고    scopus 로고
    • Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells
    • Oganesian A, Armstrong LC, Migliorini MM, Strickland DK, Bornstein P. Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 2008; 19(2): 563-571.
    • (2008) Mol Biol Cell , vol.19 , Issue.2 , pp. 563-571
    • Oganesian, A.1    Armstrong, L.C.2    Migliorini, M.M.3    Strickland, D.K.4    Bornstein, P.5
  • 44
    • 33846598411 scopus 로고    scopus 로고
    • Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)
    • Greenaway J, Lawler J, Moorehead R, Bornstein P, Lamarre J, Petrik J. Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol 2007; 210(3): 807-818.
    • (2007) J Cell Physiol , vol.210 , Issue.3 , pp. 807-818
    • Greenaway, J.1    Lawler, J.2    Moorehead, R.3    Bornstein, P.4    Lamarre, J.5    Petrik, J.6
  • 45
    • 27144541479 scopus 로고    scopus 로고
    • Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model
    • Fears CY, Grammer JR, Stewart JE, Jr., Annis DS, Mosher DF, Bornstein P, Gladson CL. Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model. Cancer Res 2005; 65(20): 9338-9346.
    • (2005) Cancer Res , vol.65 , Issue.20 , pp. 9338-9346
    • Fears, C.Y.1    Grammer, J.R.2    Stewart Jr, J.E.3    Annis, D.S.4    Mosher, D.F.5    Bornstein, P.6    Gladson, C.L.7
  • 46
    • 0035896646 scopus 로고    scopus 로고
    • Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2
    • Yang Z, Strickland DK, Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem 2001; 276(11): 8403-8408.
    • (2001) J Biol Chem , vol.276 , Issue.11 , pp. 8403-8408
    • Yang, Z.1    Strickland, D.K.2    Bornstein, P.3
  • 47
    • 0033588298 scopus 로고    scopus 로고
    • Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1
    • Krutzsch HC, Choe BJ, Sipes JM, Guo N, Roberts DD. Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1. J Biol Chem 1999; 274(34): 24080-24086.
    • (1999) J Biol Chem , vol.274 , Issue.34 , pp. 24080-24086
    • Krutzsch, H.C.1    Choe, B.J.2    Sipes, J.M.3    Guo, N.4    Roberts, D.D.5
  • 50
    • 13944267041 scopus 로고    scopus 로고
    • Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins
    • Short SM, Derrien A, Narsimhan RP, Lawler J, Ingber DE, Zetter BR. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J Cell Biol 2005; 168(4): 643-653.
    • (2005) J Cell Biol , vol.168 , Issue.4 , pp. 643-653
    • Short, S.M.1    Derrien, A.2    Narsimhan, R.P.3    Lawler, J.4    Ingber, D.E.5    Zetter, B.R.6
  • 52
    • 0024263694 scopus 로고
    • Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors
    • Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors. J Cell Biol 1988; 107: 2351-2361.
    • (1988) J Cell Biol , vol.107 , pp. 2351-2361
    • Lawler, J.1    Weinstein, R.2    Hynes, R.O.3
  • 55
    • 33746802333 scopus 로고    scopus 로고
    • Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey
    • Rusnati M, Presta M. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium 2006; 13(2): 93-111.
    • (2006) Endothelium , vol.13 , Issue.2 , pp. 93-111
    • Rusnati, M.1    Presta, M.2
  • 62
    • 0009849965 scopus 로고    scopus 로고
    • Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis
    • Gupta K, Gupta P, Wild R, Ramakrishnan S, Hebbel RP. Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 1999; 3: 147-158.
    • (1999) Angiogenesis , vol.3 , pp. 147-158
    • Gupta, K.1    Gupta, P.2    Wild, R.3    Ramakrishnan, S.4    Hebbel, R.P.5
  • 64
    • 0028625495 scopus 로고
    • Thrombospondin 1 as an enzyme inhibitor
    • Hogg PJ. Thrombospondin 1 as an enzyme inhibitor. Thrombosis and Haemostasis 1994; 72: 787-792.
    • (1994) Thrombosis and Haemostasis , vol.72 , pp. 787-792
    • Hogg, P.J.1
  • 66
    • 0031572311 scopus 로고    scopus 로고
    • Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells
    • Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 1997; 235(2): 403-412.
    • (1997) Exp Cell Res , vol.235 , Issue.2 , pp. 403-412
    • Qian, X.1    Wang, T.N.2    Rothman, V.L.3    Nicosia, R.F.4    Tuszynski, G.P.5
  • 67
    • 0034644748 scopus 로고    scopus 로고
    • Thrombospondin type 1 repeats interact with matrix metalloproteinase 2
    • Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem 2000; 275(41): 32167-32173.
    • (2000) Regulation of metalloproteinase activity. J Biol Chem , vol.275 , Issue.41 , pp. 32167-32173
    • Bein, K.1    Simons, M.2
  • 69
    • 9144259278 scopus 로고    scopus 로고
    • The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex
    • Young GD, Murphy-Ullrich JE. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. J Biol Chem 2004; 279(46): 47633-47642.
    • (2004) J Biol Chem , vol.279 , Issue.46 , pp. 47633-47642
    • Young, G.D.1    Murphy-ullrich, J.E.2
  • 71
    • 0034704174 scopus 로고    scopus 로고
    • Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain
    • Borges E, Jan Y, Ruoslahti E. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J Biol Chem 2000; 275(51): 39867-39873.
    • (2000) J Biol Chem , vol.275 , Issue.51 , pp. 39867-39873
    • Borges, E.1    Jan, Y.2    Ruoslahti, E.3
  • 72
    • 52949084316 scopus 로고    scopus 로고
    • A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells
    • Karagiannis ED, Popel AS. A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci U S A 2008; 105(37): 13775-13780.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.37 , pp. 13775-13780
    • Karagiannis, E.D.1    Popel, A.S.2
  • 73
    • 16844380395 scopus 로고    scopus 로고
    • Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model
    • Zhang X, Galardi E, Duquette M, Delic M, Lawler J, Parangi S. Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model. Clin Cancer Res 2005; 11(6): 2337-2344.
    • (2005) Clin Cancer Res , vol.11 , Issue.6 , pp. 2337-2344
    • Zhang, X.1    Galardi, E.2    Duquette, M.3    Delic, M.4    Lawler, J.5    Parangi, S.6
  • 74
    • 33845674173 scopus 로고    scopus 로고
    • Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model
    • Zhang X, Connolly C, Duquette M, Lawler J, Parangi S. Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Lett 2007; 247(1): 143-149.
    • (2007) Cancer Lett , vol.247 , Issue.1 , pp. 143-149
    • Zhang, X.1    Connolly, C.2    Duquette, M.3    Lawler, J.4    Parangi, S.5
  • 75
    • 0033027727 scopus 로고    scopus 로고
    • Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat
    • Dawson DW, Volpert OV, Pearce SF, Schneider AJ, Silverstein RL, Henkin J, Bouck NP. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. Mol Pharmacol 1999; 55(2): 332-338.
    • (1999) Mol Pharmacol , vol.55 , Issue.2 , pp. 332-338
    • Dawson, D.W.1    Volpert, O.V.2    Pearce, S.F.3    Schneider, A.J.4    Silverstein, R.L.5    Henkin, J.6    Bouck, N.P.7
  • 76
    • 0026507226 scopus 로고
    • Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
    • Asch AS, Silbiger S, Heimer E, Nachman RL. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 1992; 182(3): 1208-1217.
    • (1992) Biochem Biophys Res Commun , vol.182 , Issue.3 , pp. 1208-1217
    • Asch, A.S.1    Silbiger, S.2    Heimer, E.3    Nachman, R.L.4
  • 77
    • 0037191047 scopus 로고    scopus 로고
    • Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication
    • Tan K, Duquette M, Liu JH, Dong Y, Zhang R, Joachimiak A, Lawler J, Wang JH. Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol 2002; 159(2): 373-782.
    • (2002) J Cell Biol , vol.159 , Issue.2 , pp. 373-782
    • Tan, K.1    Duquette, M.2    Liu, J.H.3    Dong, Y.4    Zhang, R.5    Joachimiak, A.6    Lawler, J.7    Wang, J.H.8
  • 78
    • 0027449459 scopus 로고
    • Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
    • Vogel T, Guo N, Krutzsch HC, Blake DA, Hartman J, Mendelovitz S, Panet A, Roberts DD. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem 1993; 53: 74-84.
    • (1993) J Cell Biochem , vol.53 , pp. 74-84
    • Vogel, T.1    Guo, N.2    Krutzsch, H.C.3    Blake, D.A.4    Hartman, J.5    Mendelovitz, S.6    Panet, A.7    Roberts, D.D.8
  • 79
    • 0030904193 scopus 로고    scopus 로고
    • Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
    • Guo N, Krutzsch HC, Inman JK, Roberts DD. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 1997; 57(9): 1735-1742.
    • (1997) Cancer Res , vol.57 , Issue.9 , pp. 1735-1742
    • Guo, N.1    Krutzsch, H.C.2    Inman, J.K.3    Roberts, D.D.4
  • 80
    • 0030874871 scopus 로고    scopus 로고
    • Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1
    • Guo NH, Krutzsch HC, Inman JK, Shannon CS, Roberts DD. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. J Pept Res 1997; 50(3): 210-21.
    • (1997) J Pept Res , vol.50 , Issue.3 , pp. 210-221
    • Guo, N.H.1    Krutzsch, H.C.2    Inman, J.K.3    Shannon, C.S.4    Roberts, D.D.5
  • 81
    • 0027290714 scopus 로고
    • Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
    • Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993; 122(2): 497-511.
    • (1993) J Cell Biol , vol.122 , Issue.2 , pp. 497-511
    • Tolsma, S.S.1    Volpert, O.V.2    Good, D.J.3    Frazier, W.A.4    Polverini, P.J.5    Bouck, N.6
  • 82
    • 4444313333 scopus 로고    scopus 로고
    • Functions of the conserved thrombospondin carboxy-terminal cassette in cellextracellular matrix interactions and signaling
    • Adams JC. Functions of the conserved thrombospondin carboxy-terminal cassette in cellextracellular matrix interactions and signaling. Int J Biochem Cell Biol 2004; 36(6): 1102-1114.
    • (2004) Int J Biochem Cell Biol , vol.36 , Issue.6 , pp. 1102-1114
    • Adams, J.C.1
  • 83
    • 1942535754 scopus 로고    scopus 로고
    • Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats
    • Kvansakul M, Adams JC, Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. Embo J 2004; 23(6): 1223-1233.
    • (2004) Embo J , vol.23 , Issue.6 , pp. 1223-1233
    • Kvansakul, M.1    Adams, J.C.2    Hohenester, E.3
  • 84
    • 0033818524 scopus 로고    scopus 로고
    • Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays
    • Majluf-Cruz A, Manns JM, Uknis AB, Yang X, Colman RW, Harris RB, Frazier W, Lawler J, DeLa Cadena RA. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays. J Lab Clin Med 2000; 136(4): 292-302.
    • (2000) J Lab Clin Med , vol.136 , Issue.4 , pp. 292-302
    • Majluf-cruz, A.1    Manns, J.M.2    Uknis, A.B.3    Yang, X.4    Colman, R.W.5    Harris, R.B.6    Frazier, W.7    Lawler, J.8    DeLa Cadena, R.A.9
  • 85
    • 0038494616 scopus 로고    scopus 로고
    • Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion
    • Watkins NA, Du LM, Scott JP, Ouwehand WH, Hillery CA. Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion. Blood 2003; 102(2): 718-724.
    • (2003) Blood , vol.102 , Issue.2 , pp. 718-724
    • Watkins, N.A.1    Du, L.M.2    Scott, J.P.3    Ouwehand, W.H.4    Hillery, C.A.5
  • 87
    • 34447291351 scopus 로고    scopus 로고
    • Developing antiangiogenic peptide drugs for angiogenesis-related diseases
    • Sulochana KN, Ge R. Developing antiangiogenic peptide drugs for angiogenesis-related diseases. Curr Pharm Des 2007; 13(20): 2074-2086.
    • (2007) Curr Pharm Des , vol.13 , Issue.20 , pp. 2074-2086
    • Sulochana, K.N.1    Ge, R.2
  • 88
    • 34249666657 scopus 로고    scopus 로고
    • Anti-angiogenic peptides identified in thrombospondin type I domains
    • Karagiannis ED, Popel AS. Anti-angiogenic peptides identified in thrombospondin type I domains. Biochem Biophys Res Commun 2007; 359(1): 63-69.
    • (2007) Biochem Biophys Res Commun , vol.359 , Issue.1 , pp. 63-69
    • Karagiannis, E.D.1    Popel, A.S.2
  • 89
    • 34748905971 scopus 로고    scopus 로고
    • Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells
    • Karagiannis ED, Popel AS. Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells. Int J Biochem Cell Biol 2007; 39(12): 2314-2323.
    • (2007) Int J Biochem Cell Biol , vol.39 , Issue.12 , pp. 2314-2323
    • Karagiannis, E.D.1    Popel, A.S.2
  • 93
    • 34548219477 scopus 로고    scopus 로고
    • ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis
    • Anderson JC, Grammer JR, Wang W, Nabors LB, Henkin J, Stewart JE, Jr., Gladson CL. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis. Cancer Biol Ther 2007; 6(3): 454-462.
    • (2007) Cancer Biol Ther , vol.6 , Issue.3 , pp. 454-462
    • Anderson, J.C.1    Grammer, J.R.2    Wang, W.3    Nabors, L.B.4    Henkin, J.5    Stewart Jr, J.E.6    Gladson, C.L.7
  • 94
    • 20044376571 scopus 로고    scopus 로고
    • In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment
    • Quesada AJ, Nelius T, Yap R, Zaichuk TA, Alfranca A, Filleur S, Volpert OV, Redondo JM. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment. Cell Death Differ 2005; 12(6): 649-658.
    • (2005) Cell Death Differ , vol.12 , Issue.6 , pp. 649-658
    • Quesada, A.J.1    Nelius, T.2    Yap, R.3    Zaichuk, T.A.4    Alfranca, A.5    Filleur, S.6    Volpert, O.V.7    Redondo, J.M.8
  • 95
    • 38649110737 scopus 로고    scopus 로고
    • Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells
    • Isenberg JS, Yu C, Roberts DD. Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. Biochem Pharmacol 2008; 75(4): 875-882.
    • (2008) Biochem Pharmacol , vol.75 , Issue.4 , pp. 875-882
    • Isenberg, J.S.1    Yu, C.2    Roberts, D.D.3
  • 97
    • 58149521990 scopus 로고    scopus 로고
    • ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer
    • Greenaway J, Henkin J, Lawler J, Moorehead R, Petrik J. ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer. Mol Cancer Ther 2009; 8(1): 64-74.
    • (2009) Mol Cancer Ther , vol.8 , Issue.1 , pp. 64-74
    • Greenaway, J.1    Henkin, J.2    Lawler, J.3    Moorehead, R.4    Petrik, J.5
  • 98
    • 25144488561 scopus 로고    scopus 로고
    • Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy
    • Yap R, Veliceasa D, Emmenegger U, Kerbel RS, McKay LM, Henkin J, Volpert OV. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy. Clin Cancer Res 2005; 11(18): 6678-6685.
    • (2005) Clin Cancer Res , vol.11 , Issue.18 , pp. 6678-6685
    • Yap, R.1    Veliceasa, D.2    Emmenegger, U.3    Kerbel, R.S.4    McKay, L.M.5    Henkin, J.6    Volpert, O.V.7
  • 99
    • 33847701595 scopus 로고    scopus 로고
    • Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma
    • Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen HR, Henkin J, Cohn SL. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res 2007; 67(4): 1716-1724.
    • (2007) Cancer Res , vol.67 , Issue.4 , pp. 1716-1724
    • Yang, Q.1    Tian, Y.2    Liu, S.3    Zeine, R.4    Chlenski, A.5    Salwen, H.R.6    Henkin, J.7    Cohn, S.L.8
  • 100
    • 33846228382 scopus 로고    scopus 로고
    • Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers
    • Rusk A, McKeegan E, Haviv F, Majest S, Henkin J, Khanna C. Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res 2006; 12(24): 7444-7455.
    • (2006) Clin Cancer Res , vol.12 , Issue.24 , pp. 7444-7455
    • Rusk, A.1    McKeegan, E.2    Haviv, F.3    Majest, S.4    Henkin, J.5    Khanna, C.6
  • 101
    • 33846221453 scopus 로고    scopus 로고
    • Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma
    • Rusk A, Cozzi E, Stebbins M, Vail D, Graham J, Valli V, Henkin J, Sharpee R, Khanna C. Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma. Clin Cancer Res 2006; 12(24): 7456-7464.
    • (2006) Clin Cancer Res , vol.12 , Issue.24 , pp. 7456-7464
    • Rusk, A.1    Cozzi, E.2    Stebbins, M.3    Vail, D.4    Graham, J.5    Valli, V.6    Henkin, J.7    Sharpee, R.8    Khanna, C.9
  • 106
    • 33747883001 scopus 로고    scopus 로고
    • A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
    • Gietema JA, Hoekstra R, de Vos FY, Uges DR, van der Gaast A, Groen HJ, Loos WJ, Knight RA, Carr RA, Humerickhouse RA, Eskens FA. A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors. Ann Oncol 2006; 17(8): 1320-1327.
    • (2006) Ann Oncol , vol.17 , Issue.8 , pp. 1320-1327
    • Gietema, J.A.1    Hoekstra, R.2    de Vos, F.Y.3    Uges, D.R.4    Van Der Gaast, A.5    Groen, H.J.6    Loos, W.J.7    Knight, R.A.8    Carr, R.A.9    Humerickhouse, R.A.10    Eskens, F.A.11
  • 108
    • 84884455248 scopus 로고    scopus 로고
    • CVX.045: a novel thrombospondin-1 (TSP-1) mimetic CovX-Body(TM) that potentiates chemotherapy and targeted therapy in preclinical xenograft models
    • 99th Annual meeting of the American Association for Cancer Research, San Diego, CA, AACR: San Diego, CA, p Abstract nr
    • Pirie-Shepherd SR, Leedom TA, Do J, Huang H, Lingna L, Lai J, Johnson K, Osothprarop T, Rizzo JD, Doppalapudi VR, Lappe RW, Bradshaw C, Roberts S, Levin NJ, Woodnutt G CVX.045: a novel thrombospondin-1 (TSP-1) mimetic CovX-Body(TM) that potentiates chemotherapy and targeted therapy in preclinical xenograft models, 99th Annual meeting of the American Association for Cancer Research, San Diego, CA, AACR: San Diego, CA, 2008; p Abstract nr 1114.
    • (2008) , pp. 1114
    • Pirie-shepherd, S.R.1    Leedom, T.A.2    Do, J.3    Huang, H.4    Lingna, L.5    Lai, J.6    Johnson, K.7    Osothprarop, T.8    Rizzo, J.D.9    Doppalapudi, V.R.10    Lappe, R.W.11    Bradshaw, C.12    Roberts, S.13    Levin, N.J.14    Woodnutt, G.15
  • 110
    • 54549095308 scopus 로고    scopus 로고
    • Firstin-human dose escalation safety and pharmacocynetic (PK) trial of a novel intravenous (IV) thrombospondin-1 (TSP-1) mimetic humanized monoclonal CovX Body (CVX-045) in patients (pts) with advanced solid tumors
    • Mendelson DS, Dinolfa M, Cohen RB, Rosen LS, Gordon MS, Byrnes B, Bear I, Schoenfeld SL. Firstin-human dose escalation safety and pharmacocynetic (PK) trial of a novel intravenous (IV) thrombospondin-1 (TSP-1) mimetic humanized monoclonal CovX Body (CVX-045) in patients (pts) with advanced solid tumors. J Clin Oncol 2008; 26(15S): 3524.
    • (2008) J Clin Oncol , vol.26 , Issue.15 S , pp. 3524
    • Mendelson, D.S.1    Dinolfa, M.2    Cohen, R.B.3    Rosen, L.S.4    Gordon, M.S.5    Byrnes, B.6    Bear, I.7    Schoenfeld, S.L.8
  • 111
    • 62549160588 scopus 로고    scopus 로고
    • First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting
    • Molckovsky A, Siu LL. First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting. J Hematol Oncol 2008; 1(1): 20.
    • (2008) J Hematol Oncol , vol.1 , Issue.1 , pp. 20
    • Molckovsky, A.1    Siu, L.L.2
  • 112
    • 34447129571 scopus 로고    scopus 로고
    • Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin
    • Zhang X, Xu J, Lawler J, Terwilliger E, Parangi S. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res 2007; 13(13): 3968-3976.
    • (2007) Clin Cancer Res , vol.13 , Issue.13 , pp. 3968-3976
    • Zhang, X.1    Xu, J.2    Lawler, J.3    Terwilliger, E.4    Parangi, S.5
  • 114
    • 33646136232 scopus 로고    scopus 로고
    • Regulation of tumor angiogenesis by thrombospondin-1
    • Ren B, Yee KO, Lawler J, Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 2006; 1765(2): 178-188.
    • (2006) Biochim Biophys Acta , vol.1765 , Issue.2 , pp. 178-188
    • Ren, B.1    Yee, K.O.2    Lawler, J.3    Khosravi-far, R.4
  • 116
    • 0028060380 scopus 로고
    • Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
    • Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265(5178): 1582-1584.
    • (1994) Science , vol.265 , Issue.5178 , pp. 1582-1584
    • Dameron, K.M.1    Volpert, O.V.2    Tainsky, M.A.3    Bouck, N.4
  • 117
    • 0028672529 scopus 로고
    • The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin
    • Dameron KM, Volpert OV, Tainsky MA, Bouck N. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harb Symp Quant Biol 1994; 59: 483-489.
    • (1994) Cold Spring Harb Symp Quant Biol , vol.59 , pp. 483-489
    • Dameron, K.M.1    Volpert, O.V.2    Tainsky, M.A.3    Bouck, N.4
  • 118
    • 0036138149 scopus 로고    scopus 로고
    • Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis
    • Gautam A, Densmore CL, Melton S, Golunski E, Waldrep JC. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis. Cancer Gene Ther 2002; 9(1): 28-36.
    • (2002) Cancer Gene Ther , vol.9 , Issue.1 , pp. 28-36
    • Gautam, A.1    Densmore, C.L.2    Melton, S.3    Golunski, E.4    Waldrep, J.C.5
  • 120
    • 34447120138 scopus 로고    scopus 로고
    • Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1
    • Kang JH, Kim SA, Chang SY, Hong S, Hong KJ. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1. Exp Mol Med 2007; 39(3): 402-411.
    • (2007) Exp Mol Med , vol.39 , Issue.3 , pp. 402-411
    • Kang, J.H.1    Kim, S.A.2    Chang, S.Y.3    Hong, S.4    Hong, K.J.5
  • 121
    • 0026469889 scopus 로고
    • Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells
    • Castle VP, Ou X, O'Shea S, Dixit VM. Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells. J Clin Invest 1992; 90(5): 1857-1863.
    • (1992) J Clin Invest , vol.90 , Issue.5 , pp. 1857-1863
    • Castle, V.P.1    Ou, X.2    O'Shea, S.3    Dixit, V.M.4
  • 126
    • 0032893659 scopus 로고    scopus 로고
    • Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions
    • Taraboletti G, Benelli R, Borsotti P, Rusnati M, Presta M, Giavazzi R, Ruco L, Albini A. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. J Pathol 1999; 188(1): 76-81.
    • (1999) J Pathol , vol.188 , Issue.1 , pp. 76-81
    • Taraboletti, G.1    Benelli, R.2    Borsotti, P.3    Rusnati, M.4    Presta, M.5    Giavazzi, R.6    Ruco, L.7    Albini, A.8
  • 128
    • 0242331613 scopus 로고    scopus 로고
    • Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
    • Bocci G, Francia G, Man S, Lawler J, Kerbel RS. Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci U S A 2003; 100(22): 12917-12922.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , Issue.22 , pp. 12917-12922
    • Bocci, G.1    Francia, G.2    Man, S.3    Lawler, J.4    Kerbel, R.S.5
  • 129
    • 1642368865 scopus 로고    scopus 로고
    • Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression
    • Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res 2004; 64(5): 1570-1574.
    • (2004) Cancer Res , vol.64 , Issue.5 , pp. 1570-1574
    • Hamano, Y.1    Sugimoto, H.2    Soubasakos, M.A.3    Kieran, M.4    Olsen, B.R.5    Lawler, J.6    Sudhakar, A.7    Kalluri, R.8
  • 130
    • 33744503923 scopus 로고    scopus 로고
    • The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin
    • Damber JE, Vallbo C, Albertsson P, Lennernas B, Norrby K. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin. Cancer Chemother Pharmacol 2006; 58(3): 354-360.
    • (2006) Cancer Chemother Pharmacol , vol.58 , Issue.3 , pp. 354-360
    • Damber, J.E.1    Vallbo, C.2    Albertsson, P.3    Lennernas, B.4    Norrby, K.5
  • 134
    • 38649125117 scopus 로고    scopus 로고
    • Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease
    • Punekar S, Zak S, Kalter VG, Dobransky L, Punekar I, Lawler JW, Gutierrez LS. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease. Pathobiology 2008; 75(1): 9-21.
    • (2008) Pathobiology , vol.75 , Issue.1 , pp. 9-21
    • Punekar, S.1    Zak, S.2    Kalter, V.G.3    Dobransky, L.4    Punekar, I.5    Lawler, J.W.6    Gutierrez, L.S.7
  • 136
    • 0026006134 scopus 로고
    • Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma
    • Castle V, Varani J, Fligiel S, Prochownik EV, Dixit V. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J Clin Invest 1991; 87(6): 1883-1888.
    • (1991) J Clin Invest , vol.87 , Issue.6 , pp. 1883-1888
    • Castle, V.1    Varani, J.2    Fligiel, S.3    Prochownik, E.V.4    Dixit, V.5
  • 137
    • 0023522649 scopus 로고
    • Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains
    • Taraboletti G, Roberts DD, Liotta LA. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 1987; 105(5): 2409-2415.
    • (1987) J Cell Biol , vol.105 , Issue.5 , pp. 2409-2415
    • Taraboletti, G.1    Roberts, D.D.2    Liotta, L.A.3
  • 139
    • 57649139197 scopus 로고    scopus 로고
    • A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer
    • Gordon MS, Mendelson D, Carr R, Knight RA, Humerickhouse RA, Iannone M, Stopeck AT. A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer. Cancer 2008; 113(12): 3420-3429.
    • (2008) Cancer , vol.113 , Issue.12 , pp. 3420-3429
    • Gordon, M.S.1    Mendelson, D.2    Carr, R.3    Knight, R.A.4    Humerickhouse, R.A.5    Iannone, M.6    Stopeck, A.T.7
  • 140
    • 1442359994 scopus 로고    scopus 로고
    • Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice
    • Allegrini G, Goulette FA, Darnowski JW, Calabresi P. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Cancer Chemother Pharmacol 2004; 53(3): 261-266.
    • (2004) Cancer Chemother Pharmacol , vol.53 , Issue.3 , pp. 261-266
    • Allegrini, G.1    Goulette, F.A.2    Darnowski, J.W.3    Calabresi, P.4
  • 141
    • 33746542655 scopus 로고    scopus 로고
    • Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes
    • Lih CJ, Wei W, Cohen SN. Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes. Genes Dev 2006; 20(15): 2082-2095.
    • (2006) Genes Dev , vol.20 , Issue.15 , pp. 2082-2095
    • Lih, C.J.1    Wei, W.2    Cohen, S.N.3
  • 142
    • 42249115327 scopus 로고    scopus 로고
    • Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels
    • Brostjan C, Gebhardt K, Gruenberger B, Steinrueck V, Zommer H, Freudenthaler H, Roka S, Gruenberger T. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels. Clin Cancer Res 2008; 14(7): 2065-2074.
    • (2008) Clin Cancer Res , vol.14 , Issue.7 , pp. 2065-2074
    • Brostjan, C.1    Gebhardt, K.2    Gruenberger, B.3    Steinrueck, V.4    Zommer, H.5    Freudenthaler, H.6    Roka, S.7    Gruenberger, T.8
  • 145
    • 0041672462 scopus 로고    scopus 로고
    • Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts
    • Rofstad EK, Henriksen K, Galappathi K, Mathiesen B. Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts. Cancer Res 2003; 63(14): 4055-4061.
    • (2003) Cancer Res , vol.63 , Issue.14 , pp. 4055-4061
    • Rofstad, E.K.1    Henriksen, K.2    Galappathi, K.3    Mathiesen, B.4
  • 147
    • 0036098362 scopus 로고    scopus 로고
    • Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage
    • Yano K, Oura H, Detmar M. Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage. J Invest Dermatol 2002; 118(5): 800-805.
    • (2002) J Invest Dermatol , vol.118 , Issue.5 , pp. 800-805
    • Yano, K.1    Oura, H.2    Detmar, M.3
  • 149
    • 47949099628 scopus 로고    scopus 로고
    • Modes of resistance to antiangiogenic therapy
    • Bergers G, Hanahan D. Modes of resistance to antiangiogenic therapy. Nat Rev Cancer 2008; 8(8): 592-603.
    • (2008) Nat Rev Cancer , vol.8 , Issue.8 , pp. 592-603
    • Bergers, G.1    Hanahan, D.2
  • 153
    • 53149086261 scopus 로고    scopus 로고
    • Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling
    • Anderson CR, Hastings NE, Blackman BR, Price RJ. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling. Am J Pathol 2008; 173(4): 1220-1228.
    • (2008) Am J Pathol , vol.173 , Issue.4 , pp. 1220-1228
    • Anderson, C.R.1    Hastings, N.E.2    Blackman, B.R.3    Price, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.